Work

Abstract A28: BCL10 mutations define distinct dependencies guiding precision therapy for DLBCL

Year: 2022

Type: conference-abstract

Source: Blood Cancer Discovery

DOI: 10.1158/2643-3249.lymphoma22-a28

Authors: Min Xia, Liron David, Matthew R Teater, Johana Gutierrez, Xiang Wang, Cem Meydan, Andrew Lytle, Graham Slack, David Scott, Ozlem Onder, Kojo Elenitoba-Johnson, Nahuel Zamponi, Leandro Cerchietti, Tianbao Lu, Ulrike Philippar, Lorena Fontan, Hao Wu, Ari Melnick

Institutions: Weill Cornell Medicine, Harvard University, University of Pennsylvania, Janssen Research & Development (United States), Janssen (Belgium)

Language: English

Topic: NF-κB Signaling Pathways

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4294770671

Cites:

Cited by:

Related to: 10